NLRP3 and inflammatory bowel disease: The result showed that the mRNA levels of NLRP3 and its downstream caspase-1 and IL-1β significantly increased in IBD model group, compared to controls; while in CA-treated group, the mRNA levels of the three factors were obviously downregulated, compared to IBD model group (Fig. 2A).